Since the first two steps of BCAA catabolism are common for all three BCAA, a reduced BCAA catabolic flux in one of these steps forms a plausible explanation underlying the rise in plasma BCAA levels of obese insulin resistant individuals with and without T2D. The gene discussed is INS; the disease is type 2 diabetes mellitus.